Rhythm Pharmaceuticals Jumps on Reported $10 Billion AstraZeneca Bid
Rhythm Pharmaceuticals shares jumped after a report of a potential $10 billion AstraZeneca takeover, putting biotech M&A back in focus.
Gold’s 3% Surge Shows How Quickly Dollar Weakness Can Shift Macro Positioning
Gold rose roughly 3% as the dollar weakened after Democratic midterm victories, highlighting a poten…
Oil Falls on Iran De-escalation Hopes Despite Bullish US Inventory Draws
Oil prices declined as Iran de-escalation hopes clashed with sharply bullish US crude, gasoline and …
What the Democratic Midterm Sweep Means for Wall Street and Data Center Stocks
Wall Street rallied after the Democratic sweep, but data center stocks declined as traders reassesse…
Marathon Petroleum’s Refining Beat and $4.2 Billion CVR Deal Signal Downstream Consolidation
Marathon Petroleum’s refining-margin beat and $4.2 billion CVR Energy deal put US downstream consoli…
Gold Jumps 3% as Dollar Slides After Democratic Midterm Sweep Reprices Market Risk
Gold gained roughly 3% while the US dollar declined and stock futures rose after Democratic midterm …
IonQ’s Elisity Acquisition Extends Quantum Computing’s Push Into Zero Trust Security
IonQ’s all-stock acquisition of Elisity broadens its quantum security strategy across enterprise and…
KeyCorp Unit’s Atlantic-Pacific Deal Puts Fee Revenue in the Spotlight
KeyCorp’s agreement to acquire Atlantic-Pacific Capital highlights regional banks’ push into capital…
Perma-Pipe Takes Majority Stake in Welspun Coating Venture to Expand in India
Perma-Pipe’s agreement to acquire 51% of Welspun Special Coating gives PPIH majority ownership as it…
Organigram’s Aurora Bid Raises Stakes in Three-Way Cannabis Takeover Battle
Organigram’s agreement to acquire Aurora Cannabis faces a hostile Curaleaf bid, creating a pivotal t…